The Conversation: PTSD and Psychoactive Drugs: MDMA Treatment Shows Potential, but Others Lack Evidence

Summary: “To find out what the current evidence says, my colleagues and I at Phoenix Australia conducted a systematic review of the published research [on psychedelic-assisted therapies for the potential treatment of PTSD],” explains Tracey Varker, Ph.D., Senior Research Fellow at Phoenix Australia in Melbourne. Varker’s team compared results from clinical studies of ketamine-assisted psychotherapy for PTSD and MDMA-assisted psychotherapy for PTSD and identified potential risks, benefits, and efficacy of both therapies. “While there is strong evidence showing these treatments are effective, not everyone responds to them,” says Varker.

Originally appearing here.